Clinical Trial Update: Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the effect and safety of Detrol LA in men with overactive bladder symptoms, with or without bladder outlet obstruction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Detrol LA (tolterodine tartrate)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Urinary Incontinence | Phase 4 | Status: COMPLETED